SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a crypto emphasizing community, culture, and freedom within the cannabis space. Community members highlight Weedcoin as more than just a token, but a movement to connect people and ideas. With the hashtags #Weedcoin #CryptoCulture #Growth, the community is focused on building a positive and inclusive environment.

Aventus Network

Aventus Network ($AVT.X) is trending as traders discuss its potential for a breakout, pointing to its strong chart setup and real-world partnerships. Community members are drawn to its low market cap, integration with Polkadot, and enterprise use cases, suggesting it may be undervalued. Volume is a key point of focus, as traders anticipate it could drive significant price movement.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Illumina Inc

ILMN is trending amid discussions around potential acquisitions, particularly Quantum-Si ($QSI), as a strategic expansion into proteomics following the SomaLogic deal. Community interest is fueled by speculation of an upcoming announcement and bullish sentiment reflected in options activity, though some analysts debate its valuation relative to competitors in the precision oncology market. Broader discussions cover AI applications in genomics and potential catalysts that could drive significant growth for the company.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to positive Phase 3 trial results for its oral Wegovy pill, showing similar weight loss to the injectable version and potentially expanding market reach. The community is discussing the implications for market share and competition with Eli Lilly, especially with FDA approval expected soon. News of the trial results is driving optimism and renewed interest in NVO's potential.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending due to investor anticipation surrounding upcoming Phase 2 clinical data for its cystic fibrosis (CF) program, with the community hoping for positive results that could challenge Vertex's dominance in the CF treatment market. Additionally, the stock is reacting to analyst ratings and discussion of revenue potential from their COVID vaccine, Kostaive, particularly in the EU and Japan. Community members are also discussing a recent lawsuit, potential future catalysts, and potential short squeeze scenarios.

Welltower, Inc. is a health care infrastructure company, which engages in seniors housing operations, post-acute providers and health systems to fund the real estate infrastructure. The company's operating business segments include Seniors Housing Operating, Triple-Net, and Outpatient Medical. The Seniors Housing Operating segment operates properties including seniors apartments, independent living and independent supportive living, continuing care retirement communities, and assisted living, Alzheimer's dementia care and includes care homes with or without nursing. The Triple-Net segment properties offer services including independent living & supportive living (Canada), assisted living, continuing care retirement communities, Alzheimer's/dementia care and care homes with or without nursing (U.K.), and long-term/post-acute care. The Outpatient Medical segment invests in and operates outpatient medical buildings including physician offices, ambulatory surgery centers, diagnostic facilities, outpatient services and/or labs. The company was founded in 1970 and is headquartered in Toledo, OH.

Welltower Inc.

WELL is trending due to unusual options activity and analyst ratings updates, with Keybanc recently upgrading the stock to Overweight. Community members are actively discussing the potential for an impulse rally and price target levels based on Elliott Wave analysis. Some analysts highlight tailwinds from a growing senior population and rising healthcare costs, while others point to rate pressures and dividend coverage concerns.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming developments and a potential token burn at 2500 watchers. Community members are emphasizing the project's organic growth, transparency, and active development team. Many users highlight its unique standing in the meme coin space, emphasizing that $BROKE has survied longer than most meme coins.

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. is trending due to an upcoming reverse stock split, leading to concerns and discussions about potential dilution and the CEO's past actions. The community expresses frustration and distrust, with some suggesting potential strategies for trading around the split. Despite some positive news and contracts, investors are wary, and the stock's future is uncertain.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending due to anticipation surrounding topline results from its Phase 2b study of zelicapavir for RSV in high-risk adults, expected soon. Community members are closely watching for a potential catalyst, with some speculating on significant price movement based on trial outcomes. Bullish sentiment is building as the company's pipeline and potential market position are being discussed.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as precious metals gain traction, driven by speculation around central bank policy and a weaker dollar, with some anticipating a rise to $30. The community is weighing the impact of potential tariff implications and analyzing technical indicators, with many expressing bullish sentiment on the stock's long-term prospects. Despite some concerns about rising costs and mixed opinions on recent strategic decisions, the overall conversation reflects optimism for Barrick's future amid favorable conditions for gold and silver.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Dallas, TX.

MCET
MultiCell Technologies, Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MCET News

MCET MultiCell Technologies, Inc.